Eaton Vance Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $3.13M | Buy |
70,682
+1,084
| +2% | +$48K | ﹤0.01% | 914 |
|
|
2022
Q2 | $2.58M | Buy |
69,598
+13,033
| +23% | +$482K | ﹤0.01% | 1001 |
|
|
2022
Q1 | $2.1M | Buy |
56,565
+28,873
| +104% | +$1.07M | ﹤0.01% | 1165 |
|
|
2021
Q4 | $843K | Buy |
27,692
+818
| +3% | +$24.9K | ﹤0.01% | 1208 |
|
|
2021
Q3 | $885K | Sell |
26,874
-200
| -0.7% | -$6.59K | ﹤0.01% | 1117 |
|
|
2021
Q2 | $1.08M | Buy |
27,074
+604
| +2% | +$24.1K | ﹤0.01% | 1155 |
|
|
2021
Q1 | $1.19M | Hold |
26,470
| – | – | ﹤0.01% | 1097 |
|
|
2020
Q4 | $1.5M | Buy |
26,470
+547
| +2% | +$30.9K | ﹤0.01% | 986 |
|
|
2020
Q3 | $1.23M | Buy |
25,923
+2,939
| +13% | +$139K | ﹤0.01% | 942 |
|
|
2020
Q2 | $1.36M | Buy |
22,984
+3,325
| +17% | +$196K | ﹤0.01% | 897 |
|
|
2020
Q1 | $929K | Buy |
19,659
+3
| +0% | +$142 | ﹤0.01% | 925 |
|
|
2019
Q4 | $1.19M | Buy |
19,656
+3
| +0% | +$181 | ﹤0.01% | 941 |
|
|
2019
Q3 | $1.18M | Hold |
19,653
| – | – | ﹤0.01% | 915 |
|
|
2019
Q2 | $1.26M | Buy |
19,653
+11,653
| +146% | +$749K | ﹤0.01% | 894 |
|
|
2019
Q1 | $649K | Hold |
8,000
| – | – | ﹤0.01% | 1019 |
|
|
2018
Q4 | $432K | Hold |
8,000
| – | – | ﹤0.01% | 1022 |
|
|
2018
Q3 | $413K | Hold |
8,000
| – | – | ﹤0.01% | 1058 |
|
|
2018
Q2 | $333K | Sell |
8,000
-8,000
| -50% | -$333K | ﹤0.01% | 1082 |
|
|
2018
Q1 | $706K | Buy |
+16,000
| New | +$706K | ﹤0.01% | 1033 |
|